title: [The application of endolymphatic polychemotherapy in inoperative cancer of the lungs].
abstract: In 164 patients with inoperable pulmonary cancer endolymphatical infusion of cyclophosphamide and metotrexate had promoted the efficacy and security promotion of polychemotherapy conduction in comparison with such a therapy, using intravenous introduction of preparations. It was noted the increase of a life span and a five-year survival of the patients.
authors.forename: Iu I
authors.initials: IuI
authors.lastname: Iakovets
authors.forename: A G
authors.initials: AG
authors.lastname: Gonchar
authors.forename: B P
authors.initials: BP
authors.lastname: Kondratiuk
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007272:Injections, Intralymphatic; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D008875:Middle Aged; D012189:Retrospective Studies; D015996:Survival Rate; D014750:Vincristine / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D014750:Vincristine; D003520:Cyclophosphamide; D008727:Methotrexate
vernacular_title: Primenenie éndolimfaticheskoĭ polikhimioterapii pri neoperabel'nom rake legkikh.